Ethiopia's decade-long battle with measles reveals the complex challenge of achieving herd immunity in resource-constrained settings, despite meaningful vaccination progress. The country's experience offers crucial insights for other nations pursuing WHO's ambitious 2030 immunization targets.
Between 2015 and 2024, Ethiopia documented 95,904 measles cases with dramatic fluctuations—declining until 2021 before surging to peak levels in 2024. Children under five comprised approximately half of all cases, with incidence concentrated in western, southwestern, and southern regions. Seasonal patterns emerged clearly, with most transmission occurring during dry winter months when population density and respiratory transmission increase.
Vaccination coverage showed steady improvement: first-dose coverage climbed from 56% to 72%, while second-dose coverage reached 59% by 2024 after its 2019 introduction. However, these gains proved insufficient to prevent the recent resurgence.
This pattern reflects broader immunization challenges across sub-Saharan Africa, where logistical barriers, health system capacity, and crisis-related disruptions create persistent immunity gaps. Ethiopia's shifting regional hotspots suggest that national coverage statistics mask dangerous pockets of susceptibility that can seed larger outbreaks.
The 2024 surge, despite improved vaccination rates, underscores that measles elimination requires sustained coverage above 95%—a threshold that remains elusive in many low-income settings. For health-conscious adults, this analysis highlights how vaccination programs require continuous investment and monitoring, as gaps in childhood immunization can persist for years before manifesting as outbreaks.